Apyx Medical Corporation - Laporan Laba Rugi (TTM)

Apyx Medical Corporation
US ˙ NasdaqGS ˙ US03837C1062

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Apyx Medical Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 25 28 31 38 43 49 52 51 49 45 44 47 50 52 50 49 49 48 47 47
Change (%) 12.51 13.14 22.10 12.74 12.42 7.95 -1.78 -5.28 -8.65 -0.79 7.42 6.03 4.08 -3.63 -2.81 -1.00 -0.91 -1.69 -1.64
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9 10 11 12 14 15 16 16 16 15 16 17 17 19 18 19 19 19 18 18
Change (%) 10.19 7.49 13.56 12.41 6.50 10.03 -1.90 -2.60 -1.93 1.92 5.82 3.86 7.91 -1.47 2.00 2.86 -2.47 -2.83 -2.01
% of Revenue 37.61 36.83 35.00 32.55 32.45 30.74 31.34 31.30 32.19 34.55 35.49 34.97 34.25 35.51 36.30 38.10 39.59 38.96 38.51 38.37
Gross Operating Profit 15 18 20 26 29 34 36 35 33 29 28 31 33 34 32 30 29 29 29 29
Change (%) 13.91 16.43 26.69 12.90 15.27 7.02 -1.72 -6.51 -11.83 -2.22 8.30 7.20 2.08 -4.81 -5.56 -3.37 0.12 -0.97 -1.41
% of Revenue 62.39 63.17 65.00 67.45 67.55 69.26 68.66 68.70 67.81 65.45 64.51 65.03 65.75 64.49 63.70 61.90 60.41 61.04 61.49 61.63
SG&A 34 34 34 37 40 44 47 48 48 48 47 48 48 48 48 47 46 43 40 37
Change (%) -1.73 -0.02 9.53 7.59 10.23 7.87 2.28 -0.77 0.05 -2.13 1.61 1.00 0.33 -1.55 -0.49 -2.99 -6.00 -7.55 -6.98
% of Revenue 139.10 121.49 107.36 96.31 91.92 90.13 90.07 93.79 98.26 107.61 106.16 100.42 95.65 92.21 94.20 96.45 94.51 89.65 84.31 79.74
R&D 4 4 4 4 4 4 4 4 4 5 5 5 5 5 6 6 5 5 4 4
Change (%) -4.37 3.44 2.69 3.07 0.68 1.00 -0.32 -2.62 7.27 2.49 6.16 7.04 2.80 2.32 1.20 -15.32 6.50 -11.67 -13.37
% of Revenue 16.64 14.15 12.93 10.88 9.95 8.91 8.33 8.46 8.69 10.21 10.55 10.42 10.52 10.39 11.03 11.49 9.83 10.56 9.49 8.36
OpEx 48 48 49 53 58 63 68 69 68 68 67 69 71 72 71 72 70 67 63 59
Change (%) 0.37 1.87 9.87 8.36 8.62 7.91 1.11 -1.31 0.04 -0.90 2.91 2.12 2.36 -1.24 0.28 -2.43 -4.18 -6.54 -5.99
% of Revenue 193.35 172.47 155.29 139.74 134.31 129.78 129.74 133.55 139.14 152.37 152.20 145.80 140.43 138.11 141.54 146.04 143.93 139.18 132.31 126.46
Operating Income -23 -20 -17 -15 -15 -14 -16 -17 -19 -23 -23 -22 -20 -20 -21 -23 -21 -19 -15 -12
Change (%) -12.65 -13.68 -12.25 -2.65 -2.44 7.79 10.81 10.51 22.24 -1.12 -5.74 -6.42 -1.88 5.03 7.73 -5.55 -11.62 -18.91 -19.46
% of Revenue -93.35 -72.47 -55.29 -39.74 -34.31 -29.78 -29.74 -33.55 -39.14 -52.37 -52.20 -45.80 -40.43 -38.11 -41.54 -46.04 -43.93 -39.18 -32.31 -26.46
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -2 -4 -5 -5 -6 -6 -6
Change (%) -2.13 -4.35 -13.64 -57.89 -37.50 40.00 7.14 -13.33 15.38 1,506.67 224.07 74.78 81.54 46.89 24.29 18.70 10.00 -0.34 -0.58
% of Revenue -0.19 -0.17 -0.14 -0.10 -0.04 -0.02 -0.03 -0.03 -0.03 -0.03 -0.55 -1.65 -2.71 -4.73 -7.21 -9.23 -11.06 -12.28 -12.45 -12.58
Net Income -16 -12 -15 -14 -15 -15 -16 -18 -19 -23 -21 -16 -15 -19 -23 -28 -28 -23 -20 -17
Change (%) -24.72 24.80 -4.34 3.48 3.24 6.88 8.51 8.76 21.14 -10.62 -21.39 -6.97 23.48 21.87 24.39 0.26 -17.51 -14.60 -13.86
% of Revenue -64.16 -42.93 -47.35 -37.10 -34.05 -31.27 -30.96 -34.21 -39.28 -52.09 -46.93 -34.34 -30.13 -35.75 -45.20 -57.86 -58.59 -48.78 -42.37 -37.11

Source: Capital IQ

Other Listings
DE:BOV € 1.69
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista